Redefining the Diagnostic Threshold for Breast Cancer-related Lymphedema

20251 citationsJournal Article

Authors

B. Wagner · Memorial Sloan Kettering Cancer Center

Andrea V. Barrio · Memorial Sloan Kettering Cancer Center

Michelle Coriddi · Memorial Sloan Kettering Cancer Center

Jonathan Rubin · Memorial Sloan Kettering Cancer Center

Lillian A. Boe · Memorial Sloan Kettering Cancer Center

Ronnie L. Shammas · Memorial Sloan Kettering Cancer Center

Jacob Levy

Abstract

A normative, distribution-based threshold of 7.5% interlimb volume difference improves the identification of clinically meaningful BCRL compared with the traditional 10% cutoff. Adopting this empirically validated threshold may enhance early detection, intervention, and patient outcomes.

Topics & Keywords

Lymphatic System and Diseases Venous Thromboembolism Diagnosis and Management Diagnosis and Treatment of Venous Diseases

Publication Details

Published in: Annals of Surgery

DOI: 10.1097/sla.0000000000006983

Field-Weighted Citation Impact: 1.05

Command Palette

Redefining the Diagnostic Threshold for Breast Cancer-related Lymphedema

Authors

Abstract

Topics & Keywords

Publication Details